Danish firm, Aussie instiute to co-develop pathological drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2013
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...Read more
Dainippon sets up cancer drug subsidiary in the US
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2013
Singapore: Japan-based Dainippon Sumitomo Pharma (DSP), has decided to establish an anti-cancer drugs sales company in t...Read more
Japanese, Korean firm to jointly develop breast cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2015
Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agre...Read more
Novogen's chemotherapeutic agent set to enter human trial in 2015
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Dec, 2014
Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...Read more
Auspherix raises $1 mn for antibiotics
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2014
Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...Read more
Clinuvel's subisidiary develops drug candidate for vitiligo
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 May, 2015
Singapore: Australia and Switzerland based Clinuvel Pharmaceuticals' Singapore subsidiary Vallaurix has successfully com...Read more
EU supports Pyridorin drug trial for diabetic nephropathy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2015
Singapore: NephroGenex, pharmaceutical company focused on the development of therapeutics to treat kidney disease, has r...Read more
EMA to review Eli Lilly's basal insulin
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: European Medicines Agency (EMA) has accepted Eli Lilly and Boehringer Ingelheim's marketing authorisation app...Read more
Novartis' Cosentyx receives Japanese nod
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2015
Singapore: The Japanese Ministry for Health and Welfare has recently given its nod for Novatris' Cosentyx, that treats p...Read more
Aus invests $1mn in antibiotics start-up Auspherix
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2013
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has invested around $1 million in an early stage a...Read more
Japanese scientists identify genes associated with peripheral artery disease
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Oct, 2015
Tokyo: Researchers from the RIKEN Center for Integrative Medical Sciences have worked with a number of universities and...Read more
Swedish firm partners with Sanofi to expand in Asia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2015
Singapore: Sweden-based company NeuroVive Pharmaceutical's Asia arm has signed a collaboration agreement with Sanofi's a...Read more
WuXi CRO gets toxicity prediction software license
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2013
Singapore: WuXi PharmaTech, a China-based contract research organization (CRO), has obtained a multiyear license to Adme...Read more
Asthma therapy market to touch $23.1 bn by 2023
Drug Discovery | Analysis | By BioSpectrum Bureau | 4 Comment | 08 Sep, 2014
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...Read more
Nemus' glaucoma drug secures patent in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Oct, 2015
Nemus Bioscience Inc. has announced that the pro-drug of tetrahydrocannabinol (THC) in-licensed from the company's resea...Read more
Israel firm to develop epilepsy drug in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2015
Singapore: Chinese Food and Drug Administration (CFDA) has approved Israel based D-Pharm to conduct clinical development...Read more
UK pours $500 mn in genome sequencing
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2014
Singapore: In a move to accelerate genome sequencing and bring breakthrough in cancer treatment in the country, UK has...Read more
Mochida seeks Ulcerative Colitis drug approval in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Nov, 2015
Tokyo's Mochida Pharmaceutical Co. Ltd. has filed for a new drug application (NDA) for MD-0901 with the Japanese Ministr...Read more